Friday 28 August 2009

Esopraz




Esopraz may be available in the countries listed below.


Ingredient matches for Esopraz



Omeprazole

Omeprazole is reported as an ingredient of Esopraz in the following countries:


  • Greece

Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Esopraz in the following countries:


  • Greece

International Drug Name Search

Monday 24 August 2009

Ikestatina




Ikestatina may be available in the countries listed below.


Ingredient matches for Ikestatina



Somatostatin

Somatostatin x acetate (a derivative of Somatostatin) is reported as an ingredient of Ikestatina in the following countries:


  • Italy

  • Venezuela

International Drug Name Search

Wednesday 19 August 2009

Antiseptin




Antiseptin may be available in the countries listed below.


Ingredient matches for Antiseptin



Triclosan

Triclosan is reported as an ingredient of Antiseptin in the following countries:


  • Chile

International Drug Name Search

Tuesday 18 August 2009

dutasteride


doo-TAS-ter-ide


Commonly used brand name(s)

In the U.S.


  • Avodart

Available Dosage Forms:


  • Capsule, Liquid Filled

Therapeutic Class: Benign Prostatic Hypertrophy Agent


Pharmacologic Class: 5-Alpha Reductase Inhibitor


Uses For dutasteride


Note: Women of childbearing potential should not use or handle dutasteride capsules. Dutasteride can cause birth defects in male fetuses.


Dutasteride is used alone or in combination with tamsulosin (Flomax®) to treat men who have symptoms of an enlarged prostate gland, which is also known as benign prostatic hyperplasia (BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. As the prostate gland enlarges, certain muscles in the gland may become tight and get in the way of the tube that drains urine from the bladder. This can cause problems with urinating, such as a need to urinate often, a weak stream when urinating, or a feeling of not being able to empty the bladder completely.


Dutasteride blocks the action of an enzyme called 5-alpha-reductase. This enzyme changes testosterone to another hormone that causes the prostate to grow. As a result, the size of the prostate is decreased. The effect of dutasteride lasts only as long as the medicine is taken. If it is stopped, the prostate begins to grow again.


dutasteride is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, dutasteride is used in certain patients with the following medical conditions:


  • Male pattern alopecia.

Before Using dutasteride


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dutasteride, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to dutasteride or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Dutasteride is not indicated for use in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dutasteride in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersXStudies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dutasteride, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using dutasteride with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Cimetidine

  • Ciprofloxacin

  • Diltiazem

  • Ketoconazole

  • Ritonavir

  • Verapamil

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of dutasteride. Make sure you tell your doctor if you have any other medical problems, especially:


  • Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of dutasteride


Take dutasteride exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


You may take dutasteride with or without food.


Swallow the capsule whole. Do not crush, chew, or open it. The contents of the capsule may irritate your lips, mouth, or throat.


dutasteride comes with a patient information leaflet. Read and follow these instructions carefully. Ask your doctor if you have any questions.


Dosing


The dose of dutasteride will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dutasteride. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For benign prostatic hyperplasia:
      • Adults—0.5 milligram (mg) once a day.

      • Children—Use is not recommended.



Missed Dose


If you miss a dose of dutasteride, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using dutasteride


It is very important that your doctor check you at regular visits to make sure that dutasteride is working properly and to check for any unwanted effects that may be caused by dutasteride.


Women and children should not use dutasteride. Pregnant women or women who may become pregnant should not handle or touch the capsules. Dutasteride can be absorbed through the skin and can cause birth defects in male fetuses. If a pregnant woman does come in contact with dutasteride, the affected area should be washed right away with soap and water, especially if the capsule is broken.


Men who have taken dutasteride should not donate blood until 6 months have passed since the last dose. Dutasteride can remain in your blood for a long time and be passed on to a pregnant woman who receives a blood transfusion.


dutasteride may increase your risk of developing high-grade prostate cancer. Tell your doctor if you have concerns about this risk.


dutasteride may affect the results of the prostate specific antigen (PSA) test, which may be used to detect prostate cancer. Make sure you tell all of your doctors that you are using dutasteride.


dutasteride does not usually affect normal sexual abilities for most men. You may notice that you ejaculate less fluid when you have sex.


dutasteride Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Rare
  • Chest pain or discomfort

  • dilated neck veins

  • extreme fatigue

  • irregular breathing

  • irregular heartbeat

  • shortness of breath

  • swelling of the face, fingers, feet, or lower legs

  • weight gain

  • wheezing

Incidence not known
  • Blistering, flaking, or peeling of the skin

  • cough

  • difficulty with swallowing

  • dizziness

  • fast heartbeat

  • hives or welts

  • itching skin

  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • redness of the skin

  • skin rash

  • tightness in the chest

  • unusual tiredness or weakness

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Abnormal ejaculation

  • decreased interest in sexual intercourse

  • decreased sexual performance or desire

  • impotence

  • inability to have or keep an erection

  • loss in sexual ability, desire, drive, or performance

  • pain, soreness, swelling, or discharge from the breast or breasts

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: dutasteride side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More dutasteride resources


  • Dutasteride Side Effects (in more detail)
  • Dutasteride Use in Pregnancy & Breastfeeding
  • Dutasteride Drug Interactions
  • Dutasteride Support Group
  • 14 Reviews for Dutasteride - Add your own review/rating


  • Dutasteride Professional Patient Advice (Wolters Kluwer)

  • Dutasteride Monograph (AHFS DI)

  • Dutasteride MedFacts Consumer Leaflet (Wolters Kluwer)

  • Avodart Prescribing Information (FDA)

  • Avodart Consumer Overview



Compare dutasteride with other medications


  • Benign Prostatic Hyperplasia

Prostall




Prostall may be available in the countries listed below.


Ingredient matches for Prostall



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Prostall in the following countries:


  • Chile

  • Ecuador

International Drug Name Search

Monday 17 August 2009

Cesamet


Cesamet is a brand name of nabilone, approved by the FDA in the following formulation(s):


CESAMET (nabilone - capsule; oral)



  • Manufacturer: MEDA PHARMS

    Approval date: December 26, 1985

    Strength(s): 1MG [RLD]

Has a generic version of Cesamet been approved?


No. There is currently no therapeutically equivalent version of Cesamet available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cesamet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cesamet.

See also...

  • Cesamet Consumer Information (Drugs.com)
  • Cesamet Consumer Information (Wolters Kluwer)
  • Cesamet Consumer Information (Cerner Multum)
  • Cesamet Advanced Consumer Information (Micromedex)
  • Cesamet AHFS DI Monographs (ASHP)
  • Nabilone Consumer Information (Wolters Kluwer)
  • Nabilone Consumer Information (Cerner Multum)
  • Nabilone Advanced Consumer Information (Micromedex)
  • Nabilone AHFS DI Monographs (ASHP)

Saturday 15 August 2009

Amsati




Amsati may be available in the countries listed below.


Ingredient matches for Amsati



Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Amsati in the following countries:


  • Mexico

International Drug Name Search

Friday 14 August 2009

Eryhexal




Eryhexal may be available in the countries listed below.


Ingredient matches for Eryhexal



Erythromycin

Erythromycin is reported as an ingredient of Eryhexal in the following countries:


  • Luxembourg

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Eryhexal in the following countries:


  • Germany

  • Luxembourg

Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Eryhexal in the following countries:


  • Germany

  • Luxembourg

International Drug Name Search

Thursday 13 August 2009

Bioquinavir




Bioquinavir may be available in the countries listed below.


Ingredient matches for Bioquinavir



Saquinavir

Saquinavir is reported as an ingredient of Bioquinavir in the following countries:


  • Colombia

International Drug Name Search

Tuesday 11 August 2009

Néomycine Hydrocortisone




Néomycine Hydrocortisone may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Néomycine Hydrocortisone



Hydrocortisone

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Néomycine Hydrocortisone in the following countries:


  • France

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Néomycine Hydrocortisone in the following countries:


  • France

Tetracaine

Tetracaine hydrochloride (a derivative of Tetracaine) is reported as an ingredient of Néomycine Hydrocortisone in the following countries:


  • France

International Drug Name Search

Sunday 9 August 2009

Doloran




Doloran may be available in the countries listed below.


Ingredient matches for Doloran



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Doloran in the following countries:


  • Bangladesh

International Drug Name Search

Hibital




Hibital may be available in the countries listed below.


Ingredient matches for Hibital



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Hibital in the following countries:


  • Switzerland

Isopropyl Alcohol

Isopropyl Alcohol is reported as an ingredient of Hibital in the following countries:


  • Switzerland

International Drug Name Search

Thursday 6 August 2009

Alugastrin




Alugastrin may be available in the countries listed below.


Ingredient matches for Alugastrin



Carbaldrate

Carbaldrate is reported as an ingredient of Alugastrin in the following countries:


  • Poland

International Drug Name Search

Saturday 1 August 2009

Ovide


Ovide is a brand name of malathion topical, approved by the FDA in the following formulation(s):


OVIDE (malathion - lotion; topical)



  • Manufacturer: TARO PHARMS NORTH

    Approval date: August 2, 1982

    Strength(s): 0.5% [RLD][AT]

Has a generic version of Ovide been approved?


A generic version of Ovide has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ovide and have been approved by the FDA:


malathion lotion; topical



  • Manufacturer: SYNERX PHARMA

    Approval date: March 6, 2009

    Strength(s): 0.5% [AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ovide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Process for preparing malathion for pharmaceutical use
    Patent 7,560,445
    Issued: July 14, 2009
    Inventor(s): Gutman; Daniella & Baidussi; Wael
    Assignee(s): Taro Pharmaceuticals North America, Inc.
    The present invention provides a process for preparing a highly pure form of malathion having a reduced level of toxic impurities. In addition, the malathion prepared by the process of this invention is storage stable. The level of toxic impurities in the malathion, e.g., isomalathion, O,O,S-trimethyl phosphorodithioate (MeOOSPS), O,O,S-trimethyl phosphorothioate (MeOOSPO), O,S,S-trimethyl phosphorodithioate (MeOSSPO), malaoxon, isomalathion, diethyl fumarate, methyl malathion, dimethyl malathion, O,O-methyl,ethyl-S-(1,2-dicarboethoxy)ethyl-phosphorodithioate are lower than that of any other commercial preparation of malathion that may be used for pharmaceutical purposes.
    Patent expiration dates:

    • February 1, 2027
      ✓ 
      Patent use: TREATMENT OF PATIENTS INFECTED WITH PEDICULUS HUMANUS CAPITIS (HEAD LICE AND THEIR OVA) OF THE SCALP HAIR
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Process for preparing malathion for pharmaceutical use
    Patent 7,977,324
    Issued: July 12, 2011
    Inventor(s): Gutman; Daniella & Baidussi; Wael
    Assignee(s): Taro Pharmaceuticals North America, Inc.
    The present invention provides a process for preparing a highly pure form of malathion having a reduced level of toxic impurities. In addition, the malathion prepared by the process of this invention is storage stable. The level of toxic impurities in the malathion, e.g., isomalathion, O,O,S-trimethyl phosphorodithioate (MeOOSPS), O,O,S-trimethyl phosphorothioate (MeOOSPO), O,S,S-trimethyl phosphorodithioate (MeOSSPO), malaoxon, isomalathion, diethyl fumarate, methyl malathion, dimethyl malathion, O,O-methyl,ethyl-S-(1,2-dicarboethoxy)ethyl-phosphorodithioate are lower than that of any other commercial preparation of malathion that may be used for pharmaceutical purposes.
    Patent expiration dates:

    • August 14, 2026
      ✓ 
      Drug product



See also...

  • Ovide Consumer Information (Wolters Kluwer)
  • Ovide Consumer Information (Cerner Multum)
  • Ovide Topical Advanced Consumer Information (Micromedex)
  • Ovide AHFS DI Monographs (ASHP)
  • Malathion Consumer Information (Wolters Kluwer)
  • Malathion topical Consumer Information (Cerner Multum)
  • Malathion Topical Advanced Consumer Information (Micromedex)
  • Malathion AHFS DI Monographs (ASHP)